DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the target of a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 137,800 shares, a growth of 87.5% from the January 31st total of 73,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ? days.
Analyst Upgrades and Downgrades
Separately, UBS Group cut shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.
Check Out Our Latest Report on DSRLF
DiaSorin Price Performance
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Featured Articles
- Five stocks we like better than DiaSorin
- Why is the Ex-Dividend Date Significant to Investors?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
- Do ETFs Pay Dividends? What You Need to Know
- 4 Blockchain Stocks That Aren’t Coinbase
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- These 3 Tech Stocks Are Gaining Steam After NVIDIA’s Report
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.